PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 2:12 AM ET

Sponsor Check › Person

Scott Rocklage

Related person on Form D filings · address states as listed: CA, MA · listed Jun 30, 2009 → Jun 20, 2018

18issuers
67Form D filings
2009–2018years listed

Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:56 PM ET · SEC enforcement last checked: not yet

Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.

Key records

The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.

1. Lawsuits

None found in sources searched.

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:56 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

Not yet searched.

No SEC search has run yet for this person.

3. Bankruptcies

None found in sources searched.

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:56 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons are made for sponsors and sponsor groups, not individual people.

5. Money to insiders and sales commissions

1 of 46 offerings reports sales commissions totalling $1,950,000; 1 reports finder's fees totalling $1,098,482; 2 report proceeds to related persons totalling $2,000,000. (includes amounts the issuer reported as estimates)

SourceOffering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell it
EDGAR ↗Aug 5, 2020 D
File 021-372585
$0$0$0None listed on this filing
EDGAR ↗Jun 20, 2018 D
File 021-314950
$0 (est.)$0 (est.)$0 (est.)None listed on this filing
EDGAR ↗Jun 20, 2018 D
File 021-314951
$0 (est.)$0 (est.)$0 (est.)None listed on this filing
EDGAR ↗May 30, 2018 D
File 021-313514
$1,950,000$0$0None listed on this filing
EDGAR ↗Oct 31, 2017 D
File 021-297749
$0$1,098,482 (est.)$0None listed on this filing
EDGAR ↗Aug 14, 2017 D
File 021-292750
$0$0$0None listed on this filing
EDGAR ↗Jun 2, 2017 D/A
File 021-275680
$0$0$0None listed on this filing
EDGAR ↗Feb 10, 2017 D
File 021-280503
$0$0$0None listed on this filing
EDGAR ↗May 27, 2016 D
File 021-264004
$0$0$0
The Issuer is obligated to pay a management fee to the General Partner (or an affiliate thereof).
None listed on this filing
EDGAR ↗Oct 30, 2015 D
File 021-250445
$0$0$0None listed on this filing
EDGAR ↗Jun 30, 2015 D
File 021-242824
$0$0$0None listed on this filing
EDGAR ↗Jun 30, 2015 D
File 021-242825
$0$0$0None listed on this filing
EDGAR ↗Jun 30, 2015 D
File 021-242830
$0$0$0None listed on this filing
EDGAR ↗Jun 30, 2015 D
File 021-242834
$0$0$0None listed on this filing
EDGAR ↗Jun 30, 2015 D
File 021-242833
$0$0$0None listed on this filing
EDGAR ↗Jun 30, 2015 D
File 021-242832
$0$0$0None listed on this filing
EDGAR ↗Feb 17, 2015 D
File 021-234129
$0$0$0None listed on this filing
EDGAR ↗Dec 24, 2014 D
File 021-230841
$0$0$1,300,000 (est.)None listed on this filing
EDGAR ↗Jun 17, 2014 D
File 021-219307
$0$0$0None listed on this filing
EDGAR ↗Jun 17, 2014 D
File 021-219340
$0$0$0None listed on this filing
EDGAR ↗Feb 26, 2014 D
File 021-212557
$0$0$0None listed on this filing
EDGAR ↗Feb 26, 2014 D
File 021-212558
$0$0$0None listed on this filing
EDGAR ↗Feb 14, 2014 D/A
File 021-192644
$0$0$0None listed on this filing
EDGAR ↗Feb 14, 2014 D
File 021-211989
$0$0$0None listed on this filing
EDGAR ↗Feb 11, 2014 D/A
File 021-183127
$0$0$700,000 (est.)None listed on this filing
EDGAR ↗Dec 4, 2013 D
File 021-207407
$0$0$0None listed on this filing
EDGAR ↗Oct 16, 2013 D
File 021-204687
$0$0$0None listed on this filing
EDGAR ↗Mar 22, 2013 D
File 021-193796
$0$0$0None listed on this filing
EDGAR ↗Feb 22, 2013 D/A
File 021-164604
$0$0$0None listed on this filing
EDGAR ↗Jan 2, 2013 D/A
File 021-170050
$0$0$0None listed on this filing
EDGAR ↗Dec 11, 2012 D/A
File 021-182532
$0$0$0None listed on this filing
EDGAR ↗Nov 9, 2012 D
File 021-186732
$0$0$0None listed on this filing
EDGAR ↗Nov 8, 2012 D/A
File 021-166458
$0$0$0None listed on this filing
EDGAR ↗Jun 29, 2012 D
File 021-180572
$0$0$0None listed on this filing
EDGAR ↗Feb 10, 2012 D
File 021-173278
$0$0$0None listed on this filing
EDGAR ↗Aug 8, 2011 D/A
File 021-147705
$0$0$0None listed on this filing
EDGAR ↗Jul 15, 2011 D
File 021-162993
$0$0$0None listed on this filing
EDGAR ↗Jul 15, 2011 D
File 021-162994
$0$0$0None listed on this filing
EDGAR ↗May 2, 2011 D/A
File 021-127107
$0$0$0None listed on this filing
EDGAR ↗Dec 22, 2010 D
File 021-152404
$0$0$0None listed on this filing
EDGAR ↗Jul 30, 2010 D/A
File 021-141429
$0$0$0None listed on this filing
EDGAR ↗Apr 19, 2010 D
File 021-140790
$0$0$0None listed on this filing
EDGAR ↗Apr 7, 2010 D
File 021-125813
$0$0$0 (est.)
Working capital
None listed on this filing
EDGAR ↗Feb 25, 2010 D/A
File 021-136977
$0$0$0None listed on this filing
EDGAR ↗Dec 11, 2009 D/A
File 021-128190
$0$0$0None listed on this filing
EDGAR ↗Nov 2, 2009 D
File 021-66780
$0$0$0None listed on this filing

As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Appears on these filings

SourceIssuerRoleFiledFormOfferingSoldInvestorsMin. investment
EDGAR ↗Albamunity, Inc.Executive Officer, DirectorAug 5, 2020D$20,000,000
similar: $1,694,259–$16,000,000
$5,000,0006
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗HALIO, INC.DirectorJun 20, 2018D$54,620,450
similar: $1,100,015–$10,001,163
$23,585,31319
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗HALIO, INC.DirectorJun 20, 2018D$82,602,983
similar: $1,100,015–$10,001,163
$82,602,98316
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Cidara Therapeutics, Inc.
group: Trius
DirectorMay 30, 2018D$1,874,999
similar: $2,000,000–$19,999,994
$1,562,49916
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Cidara Therapeutics, Inc.
group: Trius
DirectorOct 31, 2017D$20,160,000
similar: $2,000,000–$19,999,994
$20,160,00016
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗RENNOVIA INCDirectorAug 14, 2017D$3,000,000
similar: $1,100,015–$10,001,163
$2,000,0004
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Expansion Therapeutics, Inc.Executive Officer, DirectorJun 2, 2017D/A$5,000,000
similar: $1,694,259–$16,000,000
$5,000,0003
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗RENNOVIA INCDirectorFeb 10, 2017D$6,000,000
similar: $1,100,015–$10,001,163
$3,000,0005
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Expansion Therapeutics, Inc.Executive Officer, DirectorDec 6, 2016D$4,000,000
similar: $1,694,259–$16,000,000
$250,0002
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗5AM Ventures V, L.P.Director
Managing Member of the General Partner of the Issuer
May 27, 2016D$285,000,000
similar: $155,000–$5,250,000
$285,000,00080
similar: 4–27
$25,000
similar: $1,000–$100,000
EDGAR ↗HALIO, INC.DirectorOct 30, 2015D$33,073,962
similar: $500,000–$7,000,000
$29,573,9638
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Pulmatrix, Inc.
group: Pulmatrix
DirectorJun 30, 2015D$45,468,112
similar: $1,694,259–$16,000,000
$21,383,41612
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Pulmatrix, Inc.
group: Pulmatrix
DirectorJun 30, 2015D$935,000
similar: $1,694,259–$16,000,000
$935,0001
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Pulmatrix, Inc.
group: Pulmatrix
DirectorJun 30, 2015D$687,500
similar: $1,694,259–$16,000,000
$687,5003
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Pulmatrix, Inc.
group: Pulmatrix
DirectorJun 30, 2015D$210,003
similar: $1,694,259–$16,000,000
$01
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Pulmatrix Operating Company, Inc.
group: Pulmatrix
DirectorJun 30, 2015D$1,621,422
similar: $1,694,259–$16,000,000
$1,621,4221
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Pulmatrix Operating Company, Inc.
group: Pulmatrix
DirectorJun 30, 2015D$34,124,543
similar: $1,694,259–$16,000,000
$10,000,00011
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Cidara Therapeutics, Inc.
group: Trius
DirectorFeb 17, 2015D$42,019,999
similar: $2,000,000–$19,999,994
$42,019,99919
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Novira Therapeutics, Inc.DirectorDec 24, 2014D$9,000,000
similar: $1,694,259–$16,000,000
$9,000,00010
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Cidara Therapeutics, Inc.
group: Trius
DirectorJun 17, 2014D$42,743,763
similar: $2,000,000–$19,999,994
$30,332,1998
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Cidara Therapeutics, Inc.
group: Trius
DirectorJun 17, 2014D$6,000,472
similar: $2,000,000–$19,999,994
$6,000,4721
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗HALIO, INC.DirectorFeb 26, 2014D$4,000,000
similar: $1,000,000–$10,000,000
$4,000,0004
similar: 1–11
No minimum reported
similar: $5,000–$50,000
EDGAR ↗HALIO, INC.DirectorFeb 26, 2014D$7,085,039
similar: $1,000,000–$10,000,000
$7,085,0394
similar: 1–11
No minimum reported
similar: $5,000–$50,000
EDGAR ↗RENNOVIA INCDirectorFeb 14, 2014D/A$8,000,000
similar: $1,100,015–$10,001,163
$8,000,0004
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗RENNOVIA INCDirectorFeb 14, 2014D$33,320,656
similar: $1,100,015–$10,001,163
$23,320,6585
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Novira Therapeutics, Inc.DirectorFeb 11, 2014D/A$29,800,000
similar: $1,694,259–$16,000,000
$27,995,23310
similar: 1–13
$58,230
similar: $10,000–$55,000
EDGAR ↗RENNOVIA INCDirectorDec 9, 2013D/A$7,000,000
similar: $1,100,015–$10,001,163
$7,000,0004
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗5AM Co-Investors IV, L.P.Executive OfficerDec 4, 2013D$10,000,000
similar: $155,000–$5,250,000
$10,000,00032
similar: 4–27
No minimum reported
similar: $1,000–$100,000
EDGAR ↗5AM Ventures IV, L.P.Executive OfficerOct 16, 2013D$240,000,000
similar: $155,000–$5,250,000
$00
similar: 4–27
No minimum reported
similar: $1,000–$100,000
EDGAR ↗RENNOVIA INCDirectorAug 28, 2013D/A$5,000,000$5,000,0004No minimum reported
EDGAR ↗RENNOVIA INCDirectorApr 10, 2013D/A$2,000,000$2,000,0004No minimum reported
EDGAR ↗Achaogen IncDirectorMar 22, 2013D$30,683,703$18,905,70715No minimum reported
EDGAR ↗RENNOVIA INCDirectorMar 1, 2013D$2,000,000$1,000,0004No minimum reported
EDGAR ↗Pulmatrix Operating Company, Inc.
group: Pulmatrix
DirectorFeb 22, 2013D/A$24,000,000$20,500,00011No minimum reported
EDGAR ↗RENNOVIA INCDirectorJan 2, 2013D/A$28,383,533$28,383,5334No minimum reported
EDGAR ↗Relypsa IncDirectorDec 11, 2012D/A$80,000,200$65,000,19215No minimum reported
EDGAR ↗Variation Biotechnologies (US), Inc.DirectorNov 9, 2012D$1,200,000$1,200,0004No minimum reported
EDGAR ↗HALIO, INC.DirectorNov 8, 2012D/A$16,000,000$16,000,0008No minimum reported
EDGAR ↗Pulmatrix Operating Company, Inc.
group: Pulmatrix
DirectorOct 26, 2012D/A$17,000,000$17,000,00011No minimum reported
EDGAR ↗Relypsa IncDirectorOct 5, 2012D/A$80,000,200$62,412,30414No minimum reported
EDGAR ↗Novira Therapeutics, Inc.DirectorAug 23, 2012D$26,495,221$10,995,2218$58,230
EDGAR ↗Relypsa IncDirectorAug 10, 2012D$80,000,200$49,677,65213No minimum reported
EDGAR ↗Variation Biotechnologies (US), Inc.DirectorJun 29, 2012D$1,200,000$1,200,0004No minimum reported
EDGAR ↗RENNOVIA INCDirectorJun 5, 2012D/A$28,383,333$26,383,3335No minimum reported
EDGAR ↗Variation Biotechnologies (US), Inc.DirectorFeb 10, 2012D$2,200,000$2,200,0004No minimum reported
EDGAR ↗RENNOVIA INCDirectorDec 14, 2011D$23,000,000$22,333,3334No minimum reported
EDGAR ↗HALIO, INC.DirectorSep 27, 2011D$16,000,000$9,000,0008$37,000
EDGAR ↗Pulmatrix Operating Company, Inc.
group: Pulmatrix
DirectorAug 17, 2011D$14,000,000$5,000,00011No minimum reported
EDGAR ↗Relypsa IncDirectorAug 8, 2011D/A$70,129,747$70,129,74712No minimum reported
EDGAR ↗Variation Biotechnologies (US), Inc.DirectorJul 15, 2011D$3,500,000$3,500,0004No minimum reported
EDGAR ↗Variation Biotechnologies (US), Inc.DirectorJul 15, 2011D$4,331,932$4,331,9324No minimum reported
EDGAR ↗RENNOVIA INCDirectorMay 2, 2011D/A$17,000,000$16,333,3334No minimum reported
EDGAR ↗SEMPRUS BIOSCIENCES CORPDirectorDec 22, 2010D$18,804,034$9,004,0315No minimum reported
EDGAR ↗Relypsa IncDirectorSep 14, 2010D$70,129,747$35,129,74712No minimum reported
EDGAR ↗Relypsa IncDirectorJul 30, 2010D/A$6,000,060$6,000,06011$1,600
EDGAR ↗Relypsa IncDirectorMay 3, 2010D$4,000,040$4,000,04011$3,000
EDGAR ↗Achaogen IncDirectorApr 19, 2010D$56,413,706$35,360,87315No minimum reported
EDGAR ↗WAVERX INCDirectorApr 7, 2010D$502,512$502,5123No minimum reported
EDGAR ↗5AM Co-Investors III, L.P.Executive OfficerFeb 25, 2010D/A$5,485,000$5,485,00030$25,000
EDGAR ↗5AM Co-Investors III, L.P.Executive OfficerDec 17, 2009D$2,115,000$2,115,00020$25,000
EDGAR ↗5AM VENTURES III, L.P.Executive OfficerDec 11, 2009D/A$197,825,000$197,825,00043$25,000
EDGAR ↗Pulmatrix Operating Company, Inc.
group: Pulmatrix
DirectorNov 2, 2009D$30,294,395$15,452,72810No minimum reported
EDGAR ↗RENNOVIA INCDirectorSep 4, 2009D$12,363,333$6,030,0004No minimum reported
EDGAR ↗5AM VENTURES III, L.P.Executive OfficerJul 1, 2009D/A$159,250,000$159,250,00034$25,000
EDGAR ↗RENNOVIA INCDirectorJun 30, 2009D$2,500,000$2,500,0002No minimum reported
EDGAR ↗5AM VENTURES III, L.P.Executive OfficerApr 24, 2009D/A$139,250,000$139,250,00031$25,000
EDGAR ↗5AM VENTURES III, L.P.Executive OfficerMar 19, 2009D$119,250,000$119,250,00029$25,000

Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (6 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Connections as of Oct 23, 2026, 5:45 PM ET

Listed alongside — 40 names on the same filings (2 management entities, 38 people)

People and management entities the issuers listed as related persons on the same Form D filings as Scott Rocklage. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.

  • Oculus Innovative Sciences, Inc. entity — 4 shared filings (1 issuer) · role as listed: Promoter
  • 5AM Partners V, LLC entity — 1 shared filing (1 issuer) · role as listed: Director
  • Vince Murphy — 14 shared filings (1 issuer) · role as listed: Executive Officer
  • Robert Wedinger — 13 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Steven Gillis — 13 shared filings (3 issuers) · role as listed: Director · also listed on 27 other issuers
  • Samuel Colella — 13 shared filings (1 issuer) · role as listed: Director · also listed on 10 other issuers
  • Thomas Boussie — 12 shared filings (1 issuer) · role as listed: Executive Officer
  • Kurt Swogger — 10 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Enrico Polastro — 10 shared filings (1 issuer) · role as listed: Director
  • Andrew Schwab — 9 shared filings (5 issuers) · roles as listed: Executive Officer, Director · also listed on 24 other issuers
  • Kurt Graves — 9 shared filings (2 issuers) · role as listed: Director · also listed on 5 other issuers
  • David Maki — 9 shared filings (2 issuers) · role as listed: Director
  • John Diekman — 8 shared filings (4 issuers) · role as listed: Executive Officer · also listed on 6 other issuers
  • Gerrit Klaerner — 8 shared filings (2 issuers) · roles as listed: Director, Executive Officer · also listed on 1 other issuer
  • Robert Clarke — 8 shared filings (2 issuers) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • Sam Colella — 7 shared filings (1 issuer) · role as listed: Director · also listed on 3 other issuers
  • Jerry M. Buysse — 7 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 1 other issuer
  • Ronald Krasnow — 7 shared filings (1 issuer) · role as listed: Executive Officer
  • Terrance McGuire — 6 shared filings (2 issuers) · role as listed: Director · also listed on 19 other issuers
  • Michael Higgins — 6 shared filings (2 issuers) · role as listed: Director · also listed on 6 other issuers
  • Robert Connelly — 6 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 4 other issuers
  • David Edwards — 6 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Deepa Pakianathan — 6 shared filings (1 issuer) · role as listed: Director · also listed on 2 other issuers
  • HOWARD TURNER — 6 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • SUK-BAE CHA — 6 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Kevin Forrest — 6 shared filings (2 issuers) · roles as listed: Executive Officer, Director
  • David Hava — 6 shared filings (2 issuers) · role as listed: Executive Officer
  • Jonathan T. Silverstein — 5 shared filings (1 issuer) · role as listed: Director · also listed on 32 other issuers
  • Jeffrey Stein — 5 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 3 other issuers
  • Thomas Schuetz — 5 shared filings (1 issuer) · role as listed: Director · also listed on 2 other issuers
  • Jeff Baxter — 5 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 3 other issuers
  • Egidio Nascimento — 5 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 2 other issuers
  • Lauren Silverman — 4 shared filings (1 issuer) · role as listed: Director · also listed on 6 other issuers
  • Vijay Lathi — 4 shared filings (1 issuer) · role as listed: Director · also listed on 13 other issuers
  • TERRY MCGUIRE — 4 shared filings (1 issuer) · role as listed: Director · also listed on 9 other issuers
  • HOWARD S. BERGH — 4 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Klaus Veitinger — 4 shared filings (1 issuer) · role as listed: Director · also listed on 3 other issuers
  • Hojabr Alimi — 4 shared filings (1 issuer) · roles as listed: Executive Officer, Promoter · also listed on 2 other issuers
  • William Duke — 4 shared filings (1 issuer) · role as listed: Executive Officer
  • Sameer Harish — 4 shared filings (1 issuer) · roles as listed: Executive Officer, Promoter · also listed on 2 other issuers

Other offering types (Regulation A and Regulation Crowdfunding)

None found in sources searched.

Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Export this report as PDF (members · included free during the launch period)

Change history

No corrections have been requested for this page.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Scott Rocklage appears on a new Form D, or when a court case or SEC action is matched to them. See plans →